These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3384863)

  • 1. Determination of the thromboxane synthetase inhibitor 6-(1-imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid (DP-1904) in human plasma and urine using solid-phase extraction and high-performance liquid chromatography.
    Tanaka M; Ono K; Takegoshi T
    J Chromatogr; 1988 Apr; 426(1):111-9. PubMed ID: 3384863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition and effect of the new thromboxane synthetase inhibitor 6-(1-imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid in man.
    Tanaka M; Ono K; Hakusui H; Takegoshi T; Shiozawa T; Nii S; Shibata H
    Arzneimittelforschung; 1990 Jun; 40(6):712-5. PubMed ID: 2397009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics and pharmacodynamics of a new thromboxane synthetase inhibitor, 6-(1-imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid (DP-1904) in man after repeated oral doses.
    Tanaka M; Ono K; Hakusui H; Takegoshi T; Shiozawa T; Suzuki T; Nii S; Shibata H
    J Pharm Pharmacol; 1990 Jul; 42(7):491-5. PubMed ID: 1980290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics and pharmacodynamics of a new thromboxane synthetase inhibitor, 6-(1-imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid (DP-1904), in man after single oral administration.
    Tanaka M; Ono K; Takegoshi T; Shiozawa T; Suzuki T; Nii S; Shibata H
    J Pharm Pharmacol; 1989 Oct; 41(10):680-4. PubMed ID: 2575144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic modelling of DP-1904, a novel thromboxane synthetase inhibitor in rabbits, based on an indirect response model.
    Zheng NX; Sato H; Adachi I; Horikoshi I
    Eur J Drug Metab Pharmacokinet; 1996; 21(4):285-93. PubMed ID: 9074892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of DP-1904 and its ester glucuronide in human urine and determination of their enantiomeric compositions by high-performance liquid chromatography with optical activity and ultraviolet detection.
    Tanaka M; Ono K; Hakusui H; Takegoshi T; Watanabe Y; Kanao M
    Drug Metab Dispos; 1990; 18(5):698-703. PubMed ID: 1981723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of DP-1904, a thromboxane A2 synthase inhibitor, on passive Heymann nephritis in rats.
    Nagao T; Nagamatsu T; Suzuki Y
    Eur J Pharmacol; 1996 Nov; 316(1):73-80. PubMed ID: 8982653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative analytical method for the determination of a new thromboxane synthetase inhibitor (CGS 22652) in human plasma using high performance liquid chromatography.
    Stelling MS; Maniara WM; Powell ML
    Biomed Chromatogr; 1994; 8(5):247-50. PubMed ID: 7841770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversed-phase liquid chromatographic method with amperometric detection for the determination of the dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin (N-0437) in human plasma and urine.
    Swart PJ; Drenth BF; de Zeeuw RA
    J Chromatogr; 1990 Jun; 528(2):464-72. PubMed ID: 1974552
    [No Abstract]   [Full Text] [Related]  

  • 10. Sensitive determination of a novel bisphosphonate, YM529, in plasma, urine and bone by high-performance liquid chromatography with fluorescence detection.
    Usui T; Kawakami R; Watanabe T; Higuchi S
    J Chromatogr; 1994 Jan; 652(1):67-72. PubMed ID: 8014229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of DP-1904, a thromboxane synthetase inhibitor, on antigen- and spasmogen-induced bronchoconstriction in rodents.
    Takami M; Tsukada W
    Eur J Pharmacol; 1999 Feb; 366(2-3):253-9. PubMed ID: 10082207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of cibenzoline in plasma and urine by high-performance liquid chromatography.
    Hackman MR; Lee TL; Brooks MA
    J Chromatogr; 1983 Apr; 273(2):347-56. PubMed ID: 6863449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance of liquid chromatographic determination of [3,4-di-(4-methoxyphenyl)-5-isoxazolyl]acetic acid and its metabolites in human plasma and urine.
    Marunaka T; Maniwa M
    J Chromatogr; 1987 Nov; 422():227-33. PubMed ID: 3501788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DP-1904, a specific inhibitor of thromboxane A2 synthesizing enzyme, suppresses ICAM-1 expression by stimulated vascular endothelial cells.
    Ishizuka T; Suzuki K; Kawakami M; Kawaguchi Y; Hidaka T; Matsuki Y; Nakamura H
    Eur J Pharmacol; 1994 Sep; 262(1-2):113-23. PubMed ID: 7813562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of DP-1904, a thromboxane A2 synthetase inhibitor, on crescentic nephritis in rats.
    Nagao T; Ito M; Nagamatsu T; Suzuki Y
    Eur J Pharmacol; 1994 Jul; 259(3):233-42. PubMed ID: 7982449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of a new antiulcer agent, YJA-20379-2, in human plasma and urine by high-performance liquid chromatography.
    Yoon WH; Kim SH; Chung SY; Chang MS; Choi WS; Sohn SK; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Dec; 94(3):317-22. PubMed ID: 9029677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic determination of angiotensin II receptor antagonists in human plasma and urine. I. DuP 532 (L-694,492).
    Chiou RH; Lo MW
    J Chromatogr; 1992 Oct; 581(1):165-70. PubMed ID: 1430003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly sensitive determination of imidapril, a new angiotensin I-converting enzyme inhibitor, and its active metabolite in human plasma and urine using high-performance liquid chromatography with fluorescent labelling reagent.
    Tagawa K; Hayashi K; Mizobe M; Noda K
    J Chromatogr; 1993 Jul; 617(1):95-103. PubMed ID: 8376543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane A2 synthetase inhibitors. 2. Syntheses and activities of tetrahydronaphthalene and indan derivatives.
    Kanao M; Watanabe Y; Kimura Y; Saegusa J; Yamamoto K; Kanno H; Kanaya N; Kubo H; Ashida S; Ishikawa F
    J Med Chem; 1989 Jun; 32(6):1326-34. PubMed ID: 2724303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatographic determination of triazolam and its metabolites in human urine.
    Inoue T; Suzuki S
    J Chromatogr; 1987 Nov; 422():197-204. PubMed ID: 2830292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.